Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the Bio-Shanghai Week 2026. (IMAGE)

InSilico Medicine

Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the Bio-Shanghai Week 2026.

Caption

On September 17 at 3:00 PM, during the opening ceremony's AI-Driven Innovation session, he will engage in an in-depth dialogue with Prof. Michael LEVITT - 2013 Nobel Laureate in Chemistry and Stanford University structural biology professor - on "AI-Driven Global Innovation in Therapeutic Target Discovery and Treatment Technologies".

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.